1. Home
  2. TEVA vs MTD Comparison

TEVA vs MTD Comparison

Compare TEVA & MTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • MTD
  • Stock Information
  • Founded
  • TEVA 1901
  • MTD 1991
  • Country
  • TEVA Israel
  • MTD United States
  • Employees
  • TEVA N/A
  • MTD N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • MTD Biotechnology: Laboratory Analytical Instruments
  • Sector
  • TEVA Health Care
  • MTD Industrials
  • Exchange
  • TEVA Nasdaq
  • MTD Nasdaq
  • Market Cap
  • TEVA 20.1B
  • MTD 22.4B
  • IPO Year
  • TEVA N/A
  • MTD 1997
  • Fundamental
  • Price
  • TEVA $17.15
  • MTD $1,209.08
  • Analyst Decision
  • TEVA Strong Buy
  • MTD Buy
  • Analyst Count
  • TEVA 8
  • MTD 11
  • Target Price
  • TEVA $24.50
  • MTD $1,299.45
  • AVG Volume (30 Days)
  • TEVA 10.5M
  • MTD 145.6K
  • Earning Date
  • TEVA 07-30-2025
  • MTD 07-31-2025
  • Dividend Yield
  • TEVA N/A
  • MTD N/A
  • EPS Growth
  • TEVA N/A
  • MTD 12.38
  • EPS
  • TEVA N/A
  • MTD 40.11
  • Revenue
  • TEVA $16,616,000,000.00
  • MTD $3,830,156,000.00
  • Revenue This Year
  • TEVA $5.69
  • MTD $2.31
  • Revenue Next Year
  • TEVA N/A
  • MTD $4.62
  • P/E Ratio
  • TEVA N/A
  • MTD $30.15
  • Revenue Growth
  • TEVA 3.82
  • MTD 1.18
  • 52 Week Low
  • TEVA $12.47
  • MTD $946.69
  • 52 Week High
  • TEVA $22.80
  • MTD $1,546.93
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 50.50
  • MTD 59.06
  • Support Level
  • TEVA $16.55
  • MTD $1,161.50
  • Resistance Level
  • TEVA $16.95
  • MTD $1,232.57
  • Average True Range (ATR)
  • TEVA 0.43
  • MTD 29.15
  • MACD
  • TEVA -0.06
  • MTD 1.66
  • Stochastic Oscillator
  • TEVA 45.04
  • MTD 76.73

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About MTD Mettler-Toledo International Inc.

Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 28%, China about 16% and the rest of the world about 19%.

Share on Social Networks: